Genesis HealthCare (GEN) Misses Q2 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Genesis Healthcare Reports Second Quarter 2016 Results
August 4, 2016 4:35 PM EDTKENNETT SQUARE, Pa., Aug. 4, 2016 /PRNewswire/ --Â Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United States, today announced operating results for the second quarter ended June 30, 2016.Â
Summary of Recent Financing ActivityÂ
Addresses near-term refinancing and liquidity risks by entering into a new $120 million four-year term loan agreement on July 29, 2016 and paying off the prior term loan that would have matured in December 2017; Obtains greater flexibility to operate and grow by establishing covenants with significant credit... More